SARS-CoV-2 spike protein mutations: Difference between revisions
Eric Martz (talk | contribs) No edit summary |
Eric Martz (talk | contribs) No edit summary |
||
| Line 112: | Line 112: | ||
*February 17, 2021: Cited list of >700 defined lineages<ref name="a." /><ref name="pango" />. Used lineage nomenclature more consistently, where feasible. B.1.1.7 now in 83 countries<ref name="b.1.1.7" />. | *February 17, 2021: Cited list of >700 defined lineages<ref name="a." /><ref name="pango" />. Used lineage nomenclature more consistently, where feasible. B.1.1.7 now in 83 countries<ref name="b.1.1.7" />. | ||
*March 30, 2021: Cited announcement that the UK will start variant-adapted boosters in September, 2021<ref name="ukboosters" />. | *March 30, 2021: Cited announcement that the UK will start variant-adapted boosters in September, 2021<ref name="ukboosters" />. | ||
*May 4, 2021: Added information about B.1.617 and the surge in India with several new references. | |||
==See Also== | ==See Also== | ||